Health-related quality of life during bosutinib (SKI-606) therapy in patients with advanced chronic myeloid leukemia after imatinib failure. [electronic resource]
Producer: 20170928Description: 1325-34 p. digitalISSN:- 1473-4877
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Aniline Compounds -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Blast Crisis
- Female
- Humans
- Imatinib Mesylate -- therapeutic use
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Middle Aged
- Nitriles -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Quality of Life
- Quinolines -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.